import type { ContentBlock, TocItem } from "@/lib/blog";
import solMri from "@/assets/sol-mri.jpg";

export const CHOOSING_BETWEEN_1_5T_AND_3T_MRI_TOC: TocItem[] = [
  { id: "overview", title: "The Decision in One Sentence" },
  { id: "physics-of-field-strength", title: "What Field Strength Actually Changes" },
  { id: "snr-and-resolution", title: "SNR, Resolution and Scan Time Trade-offs" },
  { id: "artefacts-and-susceptibility", title: "Artefacts, Susceptibility and Field Homogeneity" },
  { id: "sar-and-safety", title: "SAR and RF Safety at Higher Field" },
  { id: "implant-compatibility", title: "Implant and Device Compatibility" },
  { id: "clinical-fit-by-specialty", title: "Clinical Fit by Specialty" },
  { id: "siting-and-shielding", title: "Siting and Shielding Cost Differences" },
  { id: "power-and-cryogenics", title: "Power, Cooling and Cryogen Demand" },
  { id: "throughput", title: "Throughput and Scheduling Impact" },
  { id: "cost-of-ownership", title: "Total Cost of Ownership" },
  { id: "when-open-systems-make-sense", title: "When 0.3T-1.0T Open Systems Still Make Sense" },
  { id: "hybrid-fleet-strategy", title: "Building a Mixed-Field Fleet" },
  { id: "decision-framework", title: "A Practical Decision Framework" },
  { id: "procurement-checklist", title: "Procurement and Tender Checklist" },
  { id: "faq", title: "Frequently Asked Questions" },
  { id: "conclusion", title: "Conclusion" },
];

export const CHOOSING_BETWEEN_1_5T_AND_3T_MRI_CONTENT: ContentBlock[] = [
  {
    type: "intro",
    image: solMri,
    imageAlt: "1.5T and 3T MRI scanners side by side in a hospital imaging suite",
    paragraphs: [
      "Field strength is the single decision that shapes every other MRI investment a hospital makes: the room, the power supply, the shielding, the coil inventory, the referral base and the service contract. Yet it is routinely treated as a marketing question — 3T is newer, so it must be better — rather than an engineering and clinical-demand question. The physics does not support that shortcut: 3T buys real advantages in specific applications and imposes real costs and complications in others, while 1.5T remains, by a wide margin, the global clinical workhorse for good reason.",
      "This guide sets out the trade-offs that actually determine outcome quality and return on investment: signal-to-noise ratio versus susceptibility artefact, specific absorption rate limits, implant and device compatibility, siting and shielding economics, throughput under real scheduling pressure, and clinical fit case by case across neurology, orthopaedics, cardiology, body and paediatric imaging. It also covers a question too often skipped: when a low-field 0.3T-1.0T open system is the more clinically and financially rational choice than either 1.5T or 3T.",
      "None of this is abstract for a procurement team. Field strength decides bore diameter trade-offs, gradient specification, RF shielding thickness, chiller and power capacity, and, because AbuFarha Medical supplies, installs, commissions and services these systems rather than constructing the buildings that house them, it also decides what our engineering teams need from the hospital's facilities plan before a magnet ever arrives on site. Get the field-strength decision right first, and every downstream siting and staffing decision becomes simpler.",
    ],
  },
  {
    type: "keyFacts",
    covers:
      "SNR and artefact trade-offs, SAR limits, susceptibility and implant compatibility, siting and shielding cost, throughput, clinical specialty fit, low-field open systems and a structured decision framework",
    audience:
      "Hospital directors, radiology department heads, procurement committees, biomedical engineers and referring clinicians",
    readingTime: "16 min read",
    technology: "Magnetic Resonance Imaging (MRI) - field strength selection",
  },
  {
    type: "h2",
    id: "overview",
    number: 1,
    text: "The Decision in One Sentence",
    body: "Choose the lowest field strength that reliably answers your hospital's actual clinical questions, because every tesla above that adds cost, complexity and artefact risk without adding diagnostic value.",
  },
  {
    type: "ul",
    items: [
      "Field strength is not a quality ladder. It is a parameter that must be matched to case mix; a busy general hospital doing trauma, abdominal and routine neuro work often gets more real-world diagnostic throughput from a well-configured 1.5T than from an under-utilised 3T.",
      "The advantages of 3T concentrate in a narrow set of applications: prostate mpMRI, small-joint MSK, functional and susceptibility neuroimaging, and research, where the SNR gain converts directly into resolution or speed that changes management.",
      "Siting cost does not scale linearly with tesla. A 3T room typically needs materially more RF shielding, a larger quench vent, tighter power quality and often a bigger footprint than a comparable 1.5T room, and these costs are frequently underestimated at the business-case stage.",
    ],
  },
  {
    type: "takeaways",
    items: [
      "1.5T remains the correct default for most general hospitals; 3T should be justified by a named, funded clinical programme, not by prestige.",
      "SNR roughly doubles at 3T, but that gain is partly consumed by worse susceptibility artefact, higher SAR limits and less mature implant labelling.",
      "SAR rises approximately with the square of field strength, which is why sequence dictionaries and duty-cycle limits differ meaningfully between 1.5T and 3T for the same anatomy.",
      "Siting, shielding and power costs are typically higher for 3T than for an equivalent 1.5T room, an indicative range that must be confirmed with a site survey rather than assumed.",
      "Open low-field systems (0.3T-1.0T) still solve real problems: bariatric patients, severe claustrophobia, orthopaedic implants, and sites with unreliable power or limited capital.",
      "The right long-term strategy for a multi-site network is often a mixed fleet: 1.5T as the backbone, 3T where a specific programme justifies it, and open low-field where access and comfort dominate.",
    ],
  },
  {
    type: "editorialBoard",
    reviewers: [
      {
        role: "Medical reviewer",
        name: "AbuFarha Clinical Advisory Panel",
        credential: "Consultant radiologists advising on diagnostic imaging pathways",
      },
      {
        role: "Biomedical engineer",
        name: "AbuFarha Biomedical Engineering Team",
        credential: "Field service engineers for MRI, CT, cath lab and PET/CT installations",
      },
      {
        role: "Technical editor",
        name: "AbuFarha Knowledge Center Editorial Team",
        credential: "Medical technology editors, Amman, Jordan",
      },
      {
        role: "Clinical applications specialist",
        name: "AbuFarha Applications & Training Team",
        credential: "MR applications training and protocol optimisation",
      },
    ],
    lastReviewed: "July 2026",
    nextReview: "July 2027",
    version: "1.0",
    evidenceLevel:
      "Level A - international standards, peer-reviewed literature and manufacturer documentation",
    disclaimer:
      "This article is written for hospital decision-makers, clinicians and biomedical engineers as educational reference material. It is not a substitute for professional medical advice, diagnosis or treatment, nor for manufacturer instructions for use, national regulations or site-specific engineering assessment.",
  },
  {
    type: "h2",
    id: "physics-of-field-strength",
    number: 2,
    text: "What Field Strength Actually Changes",
    image: solMri,
    imagePosition: "right",
    imageAlt: "Close-up of an MRI magnet bore illustrating field strength labelling",
    body: "Field strength, measured in tesla, sets the baseline signal available before any sequence design decision is made; everything else downstream is a trade against that baseline.",
  },
  { type: "h3", text: "The Larmor relationship" },
  {
    type: "p",
    text: "Hydrogen precesses at approximately 42.58 MHz per tesla, so a 1.5T system operates near 64 MHz and a 3T system near 128 MHz. Doubling field strength does not simply double image quality; it changes RF penetration, tissue heating behaviour, chemical shift and the physics of field homogeneity simultaneously, which is why the transition from 1.5T to 3T is a genuine re-engineering of the whole imaging chain rather than a simple upgrade.",
  },
  { type: "h3", text: "Signal is the starting currency" },
  {
    type: "p",
    text: "Baseline signal-to-noise ratio increases roughly linearly with field strength, so 3T offers close to double the raw SNR of 1.5T for the same voxel size. That surplus can be spent three ways: finer spatial resolution at the same scan time, the same resolution in less time, or better contrast-to-noise for subtle pathology. Which of these a department actually needs should drive the purchase, not the tesla number itself.",
  },
  {
    type: "knowledgeBox",
    variant: "clinical-insight",
    title: "SNR is a budget, not a guarantee",
    text: "A 3T system that inherits 1.5T-era coils, shimming discipline or protocol design will not automatically outperform a well-run 1.5T service. The SNR advantage only becomes a clinical advantage when coil design, gradient performance and sequence optimisation are matched to the higher field; otherwise the surplus signal is simply spent compensating for artefact.",
  },
  {
    type: "h2",
    id: "snr-and-resolution",
    number: 3,
    text: "SNR, Resolution and Scan Time Trade-offs",
    body: "The practical question is never which field strength has more SNR but what a department wants to do with the extra signal: resolution, speed or contrast.",
  },
  {
    type: "table",
    caption: "How the SNR advantage of 3T is typically spent by application",
    headers: ["Application", "Typical use of the SNR gain", "Net clinical benefit"],
    rows: [
      ["Prostate mpMRI", "Finer in-plane resolution for PI-RADS scoring", "Improved lesion conspicuity and localisation"],
      ["Small joint, wrist and ankle MSK", "Sub-millimetre resolution of cartilage and ligaments", "Better detection of subtle tears and early cartilage loss"],
      ["Brain - routine", "Shorter scan time at equivalent quality", "Higher throughput, less motion artefact in restless patients"],
      ["Functional and susceptibility neuroimaging", "Improved BOLD contrast and microbleed conspicuity", "Better research and select clinical neuro workups"],
      ["Abdominal and pelvic body imaging", "Often consumed compensating for B1 inhomogeneity and motion", "Frequently marginal net gain over well-optimised 1.5T"],
      ["Cardiac MRI", "Mixed: better resolution but more susceptibility and B1 artefact near the chest", "Requires more sequence tuning to realise any net gain"],
    ],
  },
  {
    type: "tableInsight",
    expertCommentary: "The rows that show the clearest 3T benefit, prostate and small-joint MSK, are exactly the applications radiology literature and vendor documentation consistently cite as the justified use cases for the higher field.",
    clinicalInterpretation: "Abdominal and cardiac imaging show the smallest net gain because susceptibility and B1 field inhomogeneity at 3T partially offset the raw SNR advantage in these anatomically challenging regions.",
    hospitalRecommendation: "Before specifying 3T, ask the radiology department to name the specific protocols expected to benefit, and size the coil and software package around those protocols rather than buying a generic configuration.",
  },
  {
    type: "h2",
    id: "artefacts-and-susceptibility",
    number: 4,
    text: "Artefacts, Susceptibility and Field Homogeneity",
    body: "Higher field strength magnifies susceptibility effects, chemical shift and B1 inhomogeneity; the same physics that improves contrast can also degrade it near tissue interfaces, air and metal.",
  },
  {
    type: "p",
    text: "Susceptibility artefact, the signal loss and geometric distortion at interfaces between tissues of different magnetic susceptibility such as bone/air or tissue/metal, scales with field strength. At 3T this is more pronounced near the skull base, sinuses, bowel gas and any metallic hardware, which is why spine and orthopaedic imaging near instrumentation is frequently easier to interpret at 1.5T. Chemical shift artefact, caused by the different resonant frequency of fat versus water protons, also doubles in absolute terms at 3T, which needs to be compensated with wider receiver bandwidth or wider slice thickness margins.",
  },
  {
    type: "p",
    text: "B1 transmit field inhomogeneity is a distinctly 3T problem: the RF wavelength at 128 MHz becomes comparable to the dimensions of the human torso, causing standing-wave effects that produce uneven signal and shading, particularly in abdominal and cardiac imaging in larger patients. Dielectric padding, parallel transmit technology and B1 shimming mitigate this but add cost and protocol complexity that a 1.5T system simply does not need to solve.",
  },
  {
    type: "knowledgeBox",
    variant: "engineer-note",
    title: "Susceptibility artefact is a physics tax, not a fault",
    text: "When a 3T brain scan shows more distortion near the sinuses than the 1.5T system it replaced, this is not a shimming failure to be chased indefinitely; it is an expected consequence of field strength. Metal-artefact reduction sequences, higher receiver bandwidth and careful slice-select gradient design manage it; they do not eliminate it.",
  },
  {
    type: "h2",
    id: "sar-and-safety",
    number: 5,
    text: "SAR and RF Safety at Higher Field",
    body: "Specific absorption rate, the measure of RF energy deposited in tissue, rises approximately with the square of field strength, directly constraining which sequences can run at full parameters.",
  },
  {
    type: "p",
    text: "Because SAR scales roughly with field strength squared, a sequence that is comfortably within IEC 60601-2-33 limits at 1.5T can approach or exceed the same limits at 3T, forcing longer repetition times, reduced flip angles or parallel imaging acceleration to stay compliant. This is most noticeable in T2-weighted and fast spin-echo sequences with many closely spaced refocusing pulses, exactly the workhorse sequences of routine neuro, spine and body protocols.",
  },
  {
    type: "stats",
    items: [
      { value: "~4x", label: "Approximate SAR increase per doubling of field strength, all else equal", source: "IEC 60601-2-33 RF exposure principles" },
      { value: "42.58 MHz/T", label: "Hydrogen Larmor frequency constant" },
      { value: "~2x", label: "Approximate SNR gain moving from 1.5T to 3T" },
    ],
  },
  {
    type: "callout",
    variant: "important",
    title: "SAR limits are patient-specific, not system-specific",
    text: "SAR compliance is calculated per patient, per sequence, using body weight and exposed tissue mass. A protocol that runs cleanly on an average adult at 3T may require modification for a paediatric or bariatric patient; this is a routine part of protocol design, not an exception.",
  },
  {
    type: "h2",
    id: "implant-compatibility",
    number: 6,
    text: "Implant and Device Compatibility",
    body: "Field strength changes both the force and torque a metallic implant experiences and the RF heating it can generate, so MR-conditional labelling is field-strength specific, not universal.",
  },
  {
    type: "p",
    text: "Under ASTM F2503 and manufacturer labelling, an implant is rarely simply MRI-safe; it is MR-conditional under stated conditions that typically specify a maximum field strength (commonly 1.5T or 3T), a maximum spatial gradient and an SAR ceiling. Many older orthopaedic, aneurysm-clip and neurostimulator devices carry 1.5T-only conditional labelling, and scanning them at 3T without verified conditional clearance is a safety violation, not a quality trade-off.",
  },
  {
    type: "ul",
    items: [
      "Cardiac implantable electronic devices such as pacemakers and ICDs: a growing share are MR-conditional at both 1.5T and 3T, but legacy devices and abandoned leads generally are not, and device interrogation must precede every scan regardless of field strength.",
      "Orthopaedic hardware and aneurysm clips: many are conditional only up to 1.5T; scanning them at 3T requires explicit manufacturer documentation on file before the appointment is booked.",
      "Cochlear implants and neurostimulators: field-strength-specific restrictions are common and often require the device to be programmed into an MRI-safe mode beforehand.",
    ],
  },
  {
    type: "knowledgeBox",
    variant: "safety-alert",
    title: "Never infer conditional status from device type alone",
    text: "Two devices from the same manufacturer and model family can carry different MR-conditional labelling depending on production year. The only safe verification method is the specific implant card, manufacturer database lookup or direct manufacturer confirmation, never assumption based on device category.",
  },
  {
    type: "h2",
    id: "clinical-fit-by-specialty",
    number: 7,
    text: "Clinical Fit by Specialty",
    body: "Matching field strength to specialty case mix, rather than buying the highest tesla available, is the single highest-leverage decision in the whole procurement process.",
  },
  {
    type: "comparison",
    title: "Field strength fit by clinical specialty",
    headers: ["Specialty", "Best-fit field strength", "Rationale"],
    rows: [
      ["General radiology and trauma", "1.5T", "Balanced SNR, fast robust protocols, mature implant safety database, widest service ecosystem"],
      ["Neurology - routine", "1.5T", "Sufficient resolution for stroke, MS and routine tumour follow-up at lower SAR and artefact risk"],
      ["Neurology - functional and research", "3T", "Superior BOLD contrast and susceptibility-weighted sensitivity for microbleeds and functional mapping"],
      ["Urology - prostate mpMRI", "3T", "Higher resolution materially improves PI-RADS lesion characterisation"],
      ["Orthopaedics - large joints", "1.5T or open low-field", "Adequate resolution; lower susceptibility artefact near metal hardware"],
      ["Orthopaedics - small joints and extremities", "3T or dedicated extremity system", "Sub-millimetre detail benefits cartilage and ligament assessment"],
      ["Cardiology", "1.5T mainstream, 3T with parallel transmit", "1.5T remains the more forgiving platform for B1 homogeneity in cardiac imaging"],
      ["Paediatrics", "1.5T or 0.3T-1.0T open", "Shorter, more tolerant protocols; open systems ease sedation and anxiety needs"],
      ["Bariatric and claustrophobic patients", "0.3T-1.0T open, wide-bore 1.5T", "Physical access and patient tolerance outweigh field-strength resolution gains"],
      ["Breast MRI", "1.5T or 3T with dedicated coil", "Both viable; coil quality and protocol standardisation matter more than tesla"],
    ],
  },
  {
    type: "tableInsight",
    expertCommentary: "Only two rows in this table favour 3T unambiguously: prostate mpMRI and small-joint or extremity imaging, which is consistent with how sparingly leading radiology departments actually deploy their 3T capacity.",
    clinicalInterpretation: "Most day-to-day clinical volume in a general hospital, trauma, routine neuro, abdominal and cardiac, is served at least as well, and often more robustly, by 1.5T.",
    hospitalRecommendation: "Build the referral case-mix analysis before the tender: if fewer than roughly 15-20% of expected studies fall into the 3T-favoured column, a 1.5T purchase, or a 1.5T-plus-open-system pairing, will usually deliver more diagnostic throughput per unit invested.",
  },
  {
    type: "diagram",
    id: "field-strength-decision",
    title: "Field-strength decision pathway for a hospital imaging programme",
    purpose: "Walks a procurement or clinical planning team through the sequence of questions, case mix, implant burden, siting constraints and budget, that should determine field strength before any vendor conversation begins.",
    alt: "Decision-tree diagram starting at what is the primary case mix, branching to prostate, neuro-functional and small-joint MSK leading to 3T; to general trauma, neuro, body and cardiac leading to 1.5T; and to bariatric, claustrophobic, paediatric and limited-power-or-budget sites leading to 0.3T-1.0T open systems, with secondary branches checking implant conditional labelling, available shielded room footprint, power quality and capital budget before confirming the final field-strength recommendation.",
    caption: "Figure 1 - A structured field-strength decision pathway: case mix first, then implant and siting constraints, then budget confirmation.",
  },
  {
    type: "knowledgeBox",
    variant: "did-you-know",
    title: "Case mix, not geography, should drive the decision",
    text: "Two hospitals in the same city, one a tertiary referral centre with a prostate and neuro-oncology programme and one a general acute hospital, can reach opposite and equally correct field-strength decisions once their actual referral patterns are analysed.",
  },
  {
    type: "h2",
    id: "siting-and-shielding",
    number: 8,
    text: "Siting and Shielding Cost Differences",
    body: "RF shielding, quench venting and structural provisioning scale with field strength and fringe field extent, making 3T rooms consistently more expensive to build than 1.5T rooms of similar size.",
  },
  {
    type: "p",
    text: "The fringe field of a 3T magnet extends further than that of an equivalent 1.5T magnet, which typically demands a larger 5-gauss exclusion zone, sometimes requiring additional passive shielding in the walls, floor or ceiling depending on adjacent occupancy. RF shielding, the copper or steel Faraday enclosure, must also be specified to a stricter attenuation standard at the higher Larmor frequency of 3T, around 128 MHz, to exclude ambient RF interference, and door-seal and waveguide tolerances are tighter.",
  },
  {
    type: "table",
    caption: "Indicative siting cost drivers - 1.5T versus 3T (typical ranges, confirm with site survey)",
    headers: ["Siting element", "1.5T typical consideration", "3T typical consideration"],
    rows: [
      ["5-gauss exclusion zone", "Moderate footprint, usually contained within the room", "Larger footprint; may require additional structural shielding if adjacent to occupied space"],
      ["RF shielding attenuation", "Tuned to approximately 64 MHz", "Tuned to approximately 128 MHz; tighter seam and door-seal tolerances"],
      ["Quench vent sizing", "Standard vent path per manufacturer IFU", "Often a larger-diameter or dual-stage vent depending on magnet helium volume"],
      ["Power quality and capacity", "Standard hospital supply usually adequate with UPS for cooling", "Tighter voltage regulation and higher instantaneous gradient power demand"],
      ["Typical room footprint", "Compact wide-bore rooms achievable", "Often a larger room and equipment room footprint"],
    ],
  },
  {
    type: "tableInsight",
    expertCommentary: "None of these figures should be treated as fixed prices; every one of them is site-specific and must be confirmed by a structural and RF survey before signing a purchase agreement.",
    clinicalInterpretation: "From a clinical planning perspective, the siting premium for 3T is a real opportunity cost: capital spent on shielding and structural reinforcement is capital not spent on coils, staff training or a second scanner.",
    hospitalRecommendation: "Commission a joint siting survey covering structural, electrical and RF factors before finalising field-strength choice, and require the equipment supplier to quote siting requirements against IEC 60601-2-33 and the specific magnet's fringe-field data sheet, not generic assumptions.",
  },
  {
    type: "knowledgeBox",
    variant: "procurement",
    title: "Request the fringe-field map before you design the room",
    text: "Every magnet model publishes a fringe-field contour map in its site planning guide. Request it before architectural drawings are finalised; retrofitting shielding after a room is built is dramatically more expensive than designing it in from the start.",
  },
  {
    type: "diagram",
    id: "room-planning",
    title: "Comparative room footprint - 1.5T versus 3T magnet suite",
    purpose: "Illustrates how the 5-gauss exclusion zone, equipment room and control room footprint typically differ between a 1.5T and a 3T installation of similar clinical capacity.",
    alt: "Side-by-side floor plan comparison showing a 1.5T magnet suite with a smaller 5-gauss contour and standard equipment room, next to a 3T magnet suite with a larger 5-gauss contour, additional shielding markers on two walls, and a larger equipment room to house higher-capacity gradient amplifiers and cooling equipment.",
    caption: "Figure 2 - Typical footprint difference between a 1.5T and a 3T magnet suite; exact dimensions depend on the specific magnet model and site constraints.",
  },
  {
    type: "h2",
    id: "power-and-cryogenics",
    number: 9,
    text: "Power, Cooling and Cryogen Demand",
    body: "Gradient duty cycle and RF amplifier demand are generally higher at 3T, translating into greater instantaneous power draw and chiller capacity requirements.",
  },
  {
    type: "p",
    text: "Modern 3T systems with high-performance gradients can demand significantly more instantaneous electrical power during advanced sequences such as diffusion, functional and cardiac imaging than a comparable 1.5T system, which affects transformer sizing, harmonic filtering and, in sites with unstable grid supply, the sizing of voltage stabilisation equipment. Cryogenic demand is driven more by magnet design generation, sealed low-helium versus conventional, than by field strength itself, but 3T magnets historically carried larger helium volumes; the newest sealed 3T platforms have substantially closed that gap.",
  },
  {
    type: "knowledgeBox",
    variant: "planning-tip",
    title: "Verify grid stability before committing to 3T in constrained-power markets",
    text: "In regions with frequent voltage fluctuation or scheduled outages, the tighter power-quality tolerance of 3T gradient and RF systems can translate into more frequent fault trips than an equivalent 1.5T installation unless power conditioning is specified generously at the outset.",
  },
  {
    type: "h2",
    id: "throughput",
    number: 10,
    text: "Throughput and Scheduling Impact",
    body: "Raw scan-time comparisons favour whichever field strength is better matched to the protocol; throughput advantages are protocol-dependent, not automatic.",
  },
  {
    type: "p",
    text: "For protocols that benefit from the SNR surplus of 3T, such as diffusion, functional and high-resolution MSK imaging, acquisition time can fall meaningfully at equivalent image quality, supporting higher patient throughput. For protocols where 3T gains are largely consumed compensating for artefact, many abdominal and cardiac studies, throughput can be similar to or even worse than 1.5T once additional shimming, dielectric padding and motion-correction steps are factored in. AI-based reconstruction now narrows this gap on both platforms, but the underlying physics still determines the ceiling.",
  },
  {
    type: "knowledgeBox",
    variant: "best-practice",
    title: "Benchmark throughput on your own protocol list, not a vendor demo",
    text: "Vendor throughput claims are usually measured on protocols optimised for that specific platform. Before committing to a field strength for a high-volume department, ask for a comparative time study on the exact protocol list the department runs daily, not a curated demonstration case.",
  },
  {
    type: "h2",
    id: "cost-of-ownership",
    number: 11,
    text: "Total Cost of Ownership",
    body: "Acquisition price is only the entry cost; siting, power infrastructure, coil inventory, service contracts and helium or cryogen management determine the real multi-year cost difference between field strengths.",
  },
  {
    type: "requirements",
    checklist: [
      "Confirm whether the quoted price includes the full coil complement needed for the target protocol list",
      "Obtain a site-specific siting and shielding estimate, not a generic manufacturer planning-guide figure",
      "Request preventive maintenance and parts pricing for the specific magnet model, not a platform-wide average",
      "Clarify cryogen top-up frequency and cost for the specific magnet generation, sealed low-helium or conventional",
      "Confirm software upgrade path and licensing model over a 10-15 year expected service life",
      "Verify local service coverage and typical parts lead time for the field strength under consideration",
    ],
    specs: {
      title: "Typical cost-of-ownership differentials (indicative only)",
      rows: [
        { label: "Siting and shielding premium for 3T vs 1.5T", value: "Commonly higher; confirm with site survey" },
        { label: "Coil inventory breadth needed for equivalent case mix", value: "Similar count, higher unit cost for specialised 3T coils" },
        { label: "Power infrastructure upgrade likelihood", value: "More likely required for 3T in constrained-power sites" },
        { label: "Typical service life", value: "10-15 years for both, extendable with refurbishment" },
      ],
    },
  },
  {
    type: "knowledgeBox",
    variant: "expert-recommendation",
    title: "Model cost of ownership over the full service life, not the purchase year",
    text: "A field-strength comparison that stops at the purchase price systematically favours whichever system looks cheaper on day one. Model siting, service, coil replacement and helium management costs across a realistic 10-15 year horizon before finalising the business case.",
  },
  {
    type: "h2",
    id: "when-open-systems-make-sense",
    number: 12,
    text: "When 0.3T-1.0T Open Systems Still Make Sense",
    body: "Open low-field systems remain the correct clinical and financial choice whenever patient access, comfort or site constraints outweigh the resolution advantage of higher field strength.",
  },
  {
    type: "ul",
    items: [
      "Bariatric patients above the weight or girth limit of a standard closed-bore magnet often cannot be imaged at all on a conventional 1.5T or 3T system, making an open low-field system the only feasible imaging pathway.",
      "Severe claustrophobia, paediatric patients who cannot tolerate sedation logistics, and patients requiring a caregiver physically present during the scan are frequently served far better by an open geometry than by any closed-bore field strength.",
      "Orthopaedic and general MSK imaging away from small joints often shows acceptable diagnostic quality at low field, with the added benefit of markedly lower susceptibility artefact around metal implants.",
      "Sites with unreliable grid power, limited capital, or a genuine absence of a shielded-room-capable building often achieve a functioning, sustainable imaging service with a low-field open system where a 1.5T or 3T project would stall on infrastructure.",
    ],
  },
  {
    type: "callout",
    variant: "clinical",
    title: "Low field is a fit decision, not a downgrade",
    text: "An open 0.3T-1.0T system correctly matched to a bariatric, paediatric or access-constrained population delivers more completed diagnostic studies, not fewer, than a closed high-field system that a meaningful share of the local population physically cannot use.",
  },
  {
    type: "knowledgeBox",
    variant: "common-mistakes",
    title: "The most frequent low-field procurement mistake",
    text: "Buying an open low-field system purely on price and expecting it to substitute for 1.5T across the full case mix. Low-field systems are excellent for their matched use cases and materially weaker for small-joint MSK, prostate and functional neuroimaging; the mismatch, not the technology, causes disappointment.",
  },
  {
    type: "h2",
    id: "hybrid-fleet-strategy",
    number: 13,
    text: "Building a Mixed-Field Fleet",
    body: "Hospital networks with more than one scanner rarely need identical field strength at every site; a mixed fleet matched to each site's referral pattern typically outperforms a uniform one.",
  },
  {
    type: "p",
    text: "A tertiary referral hub with a genuine neuro-oncology, prostate or research programme justifies a 3T anchor system, while satellite or community sites in the same network are usually better served by 1.5T for general throughput, and a rehabilitation, paediatric or bariatric-heavy site may be best served by an open low-field system. Centralising complex referrals to the 3T site while keeping routine imaging local at 1.5T or open field strength is a common and effective network design.",
  },
  {
    type: "diagram",
    id: "hospital-workflow",
    title: "Referral routing across a mixed-field hospital network",
    purpose: "Shows how routine, general and specialist imaging requests can be routed to the field strength best matched to each study type across a multi-site network.",
    alt: "Workflow diagram showing referral intake at multiple hospital sites, with routine trauma, general neuro and abdominal cases routed to local 1.5T scanners, bariatric, paediatric and claustrophobic cases routed to a local open low-field scanner, and prostate mpMRI, small-joint MSK and functional neuroimaging cases routed to a central tertiary site 3T scanner.",
    caption: "Figure 3 - Referral routing logic across a mixed-field hospital network, concentrating specialist studies at the 3T site while routine volume stays local.",
  },
  {
    type: "knowledgeBox",
    variant: "future-technology",
    title: "Deployable protocol libraries are narrowing the field-strength gap",
    text: "AI-based reconstruction and deep-learning denoising are increasingly available across both 1.5T and 3T platforms, reducing scan times and improving apparent SNR at both field strengths. This narrows, but does not eliminate, the underlying physics-based differences described throughout this article.",
  },
  {
    type: "h2",
    id: "decision-framework",
    number: 14,
    text: "A Practical Decision Framework",
    body: "A structured four-step process, case mix, implant and safety review, siting feasibility and budget, produces a defensible field-strength decision far more reliably than a single specification comparison.",
  },
  {
    type: "ol" as never,
    items: [] as never,
  },
  {
    type: "ul",
    items: [
      "Step 1 - Case mix: quantify the expected annual study volume by protocol category and identify what share genuinely benefits from 3T resolution or speed.",
      "Step 2 - Population and implant profile: assess the prevalence of bariatric, claustrophobic and paediatric patients, and the local implant burden that may constrain field-strength choice.",
      "Step 3 - Siting feasibility: commission a structural, electrical and RF survey to confirm what field strength the available building and power supply can realistically support without disproportionate capital cost.",
      "Step 4 - Budget and service model: model total cost of ownership across the expected service life, including siting, coils, service contract and software upgrades, not just acquisition price.",
    ],
  },
  {
    type: "knowledgeBox",
    variant: "warning",
    title: "Do not let a single champion clinician's preference override the case-mix data",
    text: "A strong subspecialist advocate for 3T neuroimaging or prostate work is a valid input, not the whole decision. Cross-check any single-specialty preference against the department's actual aggregate referral volume before committing capital.",
  },
  {
    type: "h2",
    id: "procurement-checklist",
    number: 15,
    text: "Procurement and Tender Checklist",
    body: "A well-structured tender specifies field strength alongside coil complement, siting responsibility, service coverage and software roadmap, rather than leaving these to be negotiated after the magnet is chosen.",
  },
  {
    type: "knowledgeBox",
    variant: "quick-facts",
    title: "Tender essentials at a glance",
    items: [
      "Named field strength justified against a documented case-mix analysis",
      "Full coil complement matched to the target protocol list, priced explicitly",
      "Site-specific siting, shielding and power survey attached to the tender",
      "Preventive maintenance schedule and parts availability commitment for the specific model",
      "Software upgrade path and licensing terms for the expected service life",
      "Local training and applications support plan for the technologist and radiologist teams",
    ],
  },
  {
    type: "roi",
    paragraph: "A field-strength decision grounded in documented case mix and a full cost-of-ownership model consistently produces a shorter payback period than a decision driven by field-strength prestige, because it avoids both under-utilised premium capacity and clinically inadequate under-specification.",
    bullets: [
      "Avoids paying a 3T siting and coil premium for a case mix that would perform equally well at 1.5T",
      "Avoids under-serving a genuine 3T-favoured referral programme with an under-specified 1.5T system",
      "Reduces the risk of stranded capital from a magnet the site's power or structural infrastructure cannot support",
    ],
    callout: {
      title: "Before signing",
      lines: [
        "Confirm the case-mix analysis is signed off by the radiology department, not procurement alone",
        "Confirm the siting survey is site-specific, not a generic manufacturer estimate",
      ],
    },
  },
  {
    type: "h2",
    id: "faq",
    number: 16,
    text: "Frequently Asked Questions",
    body: "Answers to the questions hospital decision-makers most often raise when comparing field strengths.",
  },
  {
    type: "faq",
    items: [
      {
        q: "Is 3T always better than 1.5T?",
        a: "No. 3T offers roughly double the raw SNR, but this is partly offset by worse susceptibility artefact, higher SAR limits and, in some anatomical regions, more B1 inhomogeneity. The right choice depends entirely on the clinical case mix.",
      },
      {
        q: "Which specialties benefit most clearly from 3T?",
        a: "Prostate multiparametric MRI, small-joint and extremity MSK imaging, and functional or susceptibility-weighted neuroimaging show the clearest, most consistently documented benefit from 3T.",
      },
      {
        q: "Does 3T cost significantly more to install than 1.5T?",
        a: "Typically yes. RF shielding, exclusion-zone footprint, quench venting and power provisioning are usually more demanding at 3T, though the exact premium is site-specific and must be confirmed with a survey rather than assumed from a generic figure.",
      },
      {
        q: "Can every implant be scanned at 3T if it is MRI-safe at 1.5T?",
        a: "No. MR-conditional labelling under ASTM F2503 is field-strength specific. A device conditionally cleared at 1.5T is not automatically cleared at 3T, and scanning it there without verified documentation is a safety violation.",
      },
      {
        q: "Why does SAR matter more at 3T?",
        a: "Specific absorption rate rises approximately with the square of field strength, so sequences that comfortably meet IEC 60601-2-33 limits at 1.5T can approach those limits at 3T, requiring adjusted repetition times, flip angles or acceleration.",
      },
      {
        q: "Are open low-field systems obsolete?",
        a: "No. Open 0.3T-1.0T systems remain the right choice for bariatric patients beyond closed-bore weight or girth limits, severe claustrophobia, certain paediatric cases, and sites with limited power infrastructure or capital.",
      },
      {
        q: "What is susceptibility artefact and why does it get worse at higher field?",
        a: "It is signal loss and geometric distortion at interfaces between tissues of different magnetic susceptibility, such as bone, air or metal. The effect scales with field strength, so it is more pronounced at 3T, particularly near the skull base, sinuses and metallic implants.",
      },
      {
        q: "Does a hospital need a bigger room for a 3T scanner?",
        a: "Often yes. The larger fringe field and stricter RF shielding requirements at 3T frequently require a bigger exclusion zone and equipment room footprint than an equivalent 1.5T installation, though exact dimensions depend on the specific magnet model.",
      },
      {
        q: "Is throughput always higher on 3T?",
        a: "Not necessarily. Throughput gains from 3T are protocol-dependent; they are clear for diffusion, functional and high-resolution MSK studies, but often marginal or negative for abdominal and cardiac protocols once additional artefact-mitigation steps are included.",
      },
      {
        q: "Should a general hospital ever choose 3T as its sole scanner?",
        a: "Only if the case-mix analysis shows a substantial share of studies genuinely benefit from 3T. For most general hospitals, 1.5T remains the more robust single-scanner choice, with 3T reserved for sites with a specific, funded specialist programme.",
      },
      {
        q: "How does field strength affect power and cooling requirements?",
        a: "3T systems generally demand higher instantaneous electrical power for gradient and RF performance, which can require larger transformers and tighter power-quality management, particularly in regions with unstable grid supply.",
      },
      {
        q: "What is the most common mistake hospitals make when choosing field strength?",
        a: "Selecting field strength based on perceived prestige or a single specialist's preference rather than a documented, department-wide case-mix and cost-of-ownership analysis covering the full expected service life.",
      },
      {
        q: "Can a hospital run a mixed fleet of different field strengths?",
        a: "Yes, and for multi-site networks this is often the most efficient approach: a 3T anchor for specialist referrals, 1.5T for general throughput at satellite sites, and open low-field systems where patient access is the priority.",
      },
    ],
  },
  {
    type: "h2",
    id: "conclusion",
    number: 17,
    text: "Conclusion",
    body: "Field strength should be the output of a case-mix and siting analysis, not the starting assumption of a procurement process.",
  },
  {
    type: "p",
    text: "There is no universally correct field strength. 1.5T remains the balanced, broadly capable default for most general hospitals; 3T earns its higher cost and complexity only where a documented, funded clinical programme, most clearly prostate mpMRI, small-joint MSK and functional neuroimaging, will genuinely use the extra signal; and open low-field systems remain the right answer wherever patient access, comfort or site infrastructure outweigh resolution. Approached in that order, case mix first, implant and safety profile second, siting feasibility third, budget last, the field-strength decision becomes a defensible engineering and clinical conclusion rather than a specification-sheet impulse purchase.",
  },
  {
    type: "referenceGroups",
    note: "References are provided for professional orientation. Always follow the current edition of each standard, the applicable national regulations, and the manufacturer's instructions for use for your specific system.",
    groups: [
      {
        title: "Medical guidelines",
        items: [
          { label: "American College of Radiology. ACR Manual on MR Safety - field strength considerations, implant screening and four-zone access control." },
          { label: "ACR-NASCI-SPR. Practice Parameter for the Performance and Interpretation of Magnetic Resonance Imaging." },
          { label: "PI-RADS Steering Committee. Prostate Imaging Reporting and Data System - field strength recommendations for multiparametric prostate MRI." },
        ],
      },
      {
        title: "Scientific publications",
        items: [
          { label: "Peer-reviewed comparative studies on 1.5T versus 3T diagnostic performance in neuroimaging, prostate mpMRI and musculoskeletal imaging, published in the radiology literature." },
          { label: "Peer-reviewed literature on specific absorption rate scaling and RF safety at increasing static field strength." },
        ],
      },
      {
        title: "Regulatory authorities",
        items: [
          { label: "U.S. Food and Drug Administration. MRI (Magnetic Resonance Imaging) - device safety, labelling and field-strength-specific conditional clearance guidance." },
          { label: "Medicines and Healthcare products Regulatory Agency (MHRA). Safety guidelines for magnetic resonance imaging equipment in clinical use." },
          { label: "European Commission. Medical Device Regulation (EU) 2017/745 - requirements for placing MR systems on the EU market." },
        ],
      },
      {
        title: "International standards",
        items: [
          { label: "IEC 60601-2-33. Particular requirements for the basic safety and essential performance of magnetic resonance equipment for medical diagnosis." },
          { label: "ASTM F2503. Standard Practice for Marking Medical Devices and Other Items for Safety in the Magnetic Resonance Environment." },
          { label: "NEMA MS series. Standards for determination of signal-to-noise ratio, image uniformity and geometric distortion in diagnostic MR imaging." },
        ],
      },
      {
        title: "Manufacturer documentation",
        items: [
          { label: "Siemens Healthineers, GE HealthCare, Philips, Canon Medical Systems and Fujifilm Healthcare - site planning guides, fringe-field data sheets and instructions for use for 1.5T, 3T and open low-field platforms." },
          { label: "Manufacturer implant conditional-labelling databases and MR-conditional device documentation." },
        ],
      },
      {
        title: "Medical societies",
        items: [
          { label: "International Society for Magnetic Resonance in Medicine (ISMRM) - field strength selection and MR safety resources." },
          { label: "Radiological Society of North America (RSNA) - clinical MRI education material on field strength trade-offs." },
          { label: "European Society of Radiology (ESR) - imaging referral guidelines and quality standards." },
        ],
      },
    ],
  },
  {
    type: "articleCta",
    heading: "Not sure whether 1.5T, 3T or open MRI is right for your hospital?",
    subheading: "Our clinical applications team and biomedical engineers help hospitals across Africa and the Middle East analyse case mix, siting feasibility and total cost of ownership before committing to a field strength.",
    technology: "MRI",
  },
];
